Effects of Parabolic Flight on Spatial Cognition and Hippocampal Plasticity
NCT ID: NCT02789007
Last Updated: 2022-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2016-03-31
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A preliminary study will be performed with the aims (1) to test during weightlessness hardware used to administer visuo-spatial testing and (2) to determine the optimal body posture for testing under microgravity conditions (i.e. body posture for which change in visuo-spatial testing induced by weightlessness is maximal).
The main criteria are:
* Structural and functional changes of brain evaluated by fMRI;
* Cognitive performance, and specifically spatial cognition using a series computer-based tasks.
* Key neurotrophins determined in venous blood samples The criteria used in the preliminary experiment is visuo-spatial performance evaluated with a computer-based test assessing spatial cognition.
The investigators hypothesize that hippocampal structure and function, and particularly the dentate gyrus, will be altered after parabolic flight compared to ground based controls. Specifically, the 3 tested hypotheses are:
* Parabolic flight induces changes in hippocampal structure;
* Weightlessness induces changes in cognitive performance, and specifically spatial cognition;
* There is a correlation between changes in hippocampal structure and changes in visuo-spatial memory performance.
* There is a correlation between changes in hippocampal structure and changes in key neurotrophins.
The hypothesis tested during the preliminary experiment is that body posture affects the changes in spatial cognition performance.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Parabolic Flight Induced Neuroplasticity Studied With Advanced Magnetic Resonance Imaging Methods
NCT02517216
Spatial Orientation and Motor Skills: How to Flip Switches "Down" in Weightlessness?
NCT02850380
Coherence Between Brain Cortical Function and Neurocognitive Performance During Changed Gravity Conditions
NCT02516787
Operational Performance Effects and Neurophysiology in Partial Gravity
NCT06736652
Vestibular Disorder and Visuo-spatial Functions
NCT02533739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
parabolic flight
To evaluate Structural and functional changes, Cognitive performance, and specifically spatial cognition, Key neurotrophins...
Assess the impact of parabolic flight
MRI testing will be performed using a 3T MRI facility in Bordeaux close to Novespace (CHU Pellegrin).
Spatial cognition will be assessed using a battery of in-house virtual paradigms General cognitive performance testing will include a wide range of cognitive functions, and particularly executive control using the Cognition Battery Mental status will be assessed on a tablet computer using a visual analogue scale Vigilant attention will be determined using the 3-min Psychomotor Vigilance Test (PVT) Blood samples (5 mL per collection) will be collected prior to neuroimaging by venepuncture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Assess the impact of parabolic flight
MRI testing will be performed using a 3T MRI facility in Bordeaux close to Novespace (CHU Pellegrin).
Spatial cognition will be assessed using a battery of in-house virtual paradigms General cognitive performance testing will include a wide range of cognitive functions, and particularly executive control using the Cognition Battery Mental status will be assessed on a tablet computer using a visual analogue scale Vigilant attention will be determined using the 3-min Psychomotor Vigilance Test (PVT) Blood samples (5 mL per collection) will be collected prior to neuroimaging by venepuncture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged from 18 to 67
* Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC)
* Who accepted to take part in the study
* Who have given their written stated consent
* Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection.
Subjects will be staff member of the team or of other teams participating in the parabolic flight campaign.
Exclusion Criteria
* Person with medical history of claustrophobia
* Person with contraindication to MRI
* Pregnant women
18 Years
67 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novespace
INDUSTRY
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre DP Denise, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU CAEN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Caen CHU
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A02014-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.